LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) Cash from Operations (2015 - 2026)

LivaNova's (LIVN) quarterly Cash from Operations came in at $66.6 million in Q2 2026, up 5.83% year-over-year from $62.9 million in Q2 2025, and up 337.62% quarter-over-quarter from $15.2 million in Q1 2026.

Analysis

LivaNova (LIVN) Cash from Operations (2015 - 2026) Analysis & Trends

LivaNova has disclosed Cash from Operations across 12 years of filings, most recently posting $66.6 million for Q2 2026.

  • In Q2 2026, Cash from Operations rose 5.83% year-over-year to $66.6 million; the TTM figure through Jun 2026 stood at $249.3 million (up 15.08% YoY), while the FY2025 annual figure was $254.3 million, up 38.95% from the prior year.
  • Cash from Operations came in at $66.6 million for Q2 2026 at LivaNova, up from $15.2 million in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of $85.1 million in Q3 2025 to a low of -$17.9 million in Q2 2023.
  • Average Cash from Operations over 5 years is $36.9 million, with a median of $30.7 million recorded in 2022.
  • Year-over-year, Cash from Operations slumped 139.96% in 2022 and jumped 341.71% in 2024.
  • Over 5 years, Cash from Operations stood at $18.7 million in 2022, then surged by 188.5% to $54.0 million in 2023, then soared by 45.87% to $78.7 million in 2024, then climbed by 4.69% to $82.4 million in 2025, then decreased by 19.19% to $66.6 million in 2026.
  • Per Business Quant data, the three most recent Cash from Operations figures were $66.6 million in Q2 2026, $15.2 million in Q1 2026, and $82.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 2.49 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 1.06 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 1.79 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 1.26 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 1.47 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 651.90 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 510.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 269.20 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 367.10 Mn
10 LivaNova 4.34 Bn 3.82 Bn 273.67 Mn 66.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 66.59 Mn
Mar 31, 2026 15.22 Mn
Dec 31, 2025 82.40 Mn
Sep 30, 2025 85.06 Mn
Jun 30, 2025 62.92 Mn
Mar 31, 2025 23.97 Mn
Dec 31, 2024 78.71 Mn
Sep 30, 2024 50.99 Mn
Jun 30, 2024 43.36 Mn
Mar 31, 2024 9.98 Mn
Dec 31, 2023 53.96 Mn
Sep 30, 2023 18.14 Mn
Jun 30, 2023 -17.94 Mn
Mar 31, 2023 20.76 Mn
Dec 31, 2022 18.70 Mn
Sep 30, 2022 35.64 Mn
Jun 30, 2022 -10.24 Mn
Mar 31, 2022 25.82 Mn
Dec 31, 2021 33.48 Mn
Sep 30, 2021 23.95 Mn